GCIG-Consensus Guideline for Long-term survivorship in Gynecologic Cancer: a position paper from the Gynecologic Cancer Intergroup (GCIG) symptom benefit committee

The incidence of gynecological cancers is rising due to the increasing age of the population and environmental factors, with 14 million new cancer diagnoses each year. However, due to improved screening methods and treatment strategies, the number of long-term gynecologic cancer survivors is also increasing. A large number of patients with endometrial, vulvar and cervical cancer are cured with treatment and a third of patients with ovarian cancers become long-term survivors [1]. Recommendations for cancer survivorship care have been published stressing the need for survivorship care planning and coordination between specialists and primary health care providers (i.e., general practitioners).

Source: Cancer Treatment Reviews - April 30, 2022 Category: Cancer & Oncology Authors: H. Woopen, J. Sehouli, A. Davis, Y.C. Lee, P.A. Cohen, A. Ferrero, N. Gleeson, A. Jhingran, Y. Kajimoto, J. Mayadev, M.P. Barretina-Ginesta, S. Sundar, N. Suzuki, E. van Dorst, F. Joly Source Type: research